53
Participants
Start Date
January 31, 2017
Primary Completion Date
November 23, 2020
Study Completion Date
November 23, 2020
Crofelemer
Crofelemer 125 mg BID during cycles 1-2 of THP or TCHP
Lombardi Comprehensive Cancer Center, Washington D.C.
MedStar Franklin Square Cancer Center at Loch Raven Campus, Baltimore
Harry and Jeanette Weinberg Cancer Institute, Baltimore
John Theurer Cancer Center at Hackensack Univ, Hackensack
Lombardi Comprehensive Cancer Center
OTHER
Medstar Health Research Institute
OTHER
Genentech, Inc.
INDUSTRY
Napo Pharmaceuticals, Inc.
INDUSTRY
Sandra Swain
OTHER